|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Is oral contraceptive use still associated with an increased risk of fatal |
| myocardial infarction? Report of a case-control study. |
| Thorogood M; Mann J; Murphy M; Vessey M |
| OBSTETRICAL AND GYNECOLOGICAL SURVEY. 1992 Jul;47(7):512-4. |
| Physicians from Oxford University in England and from the University of Otago in Dunedin, New Zealand, compared |
| data on 161 women who died of myocardial infarction with data on 309 women matched for age and marital status to |
| determine whether the relative risk of fatal myocardial infarction associated with oral contraceptive (OC) use has |
| fallen. The relative risk of fatal myocardial infarction was 1.1 among current OC users and 1.4 among past OC users. |
| The relative risk of both current and past OC users. The relative risk of both current and past OC use together was |
| 1.9. Cases used OCs with 50 mcg of estrogen at a rate more than 3 times that of controls. The relative risk of fatal |
| myocardial infarction for current use of a 50 mcg estrogen OC was 4.2. Almost 50% of cases used progestin-only |
| OCs, however. Smoking likely had a confounding effect on the relative risk of myocardial infarction with OC use, but |
| the data prevented the researchers from quantitatively analyzing smoking's effect. This case control study showed an |
| increased risk of myocardial infarction in women with a history of preeclampsia/eclampsia, nonpregnancy- |
| associated hypertension, hyperlipidemia, and diabetes mellitus. These findings suggested that the risk of fatal |
| myocardial infarction in healthy women using lower dose OCs is very small. If larger studies would confirm these |
| findings and if studies examining nonfatal myocardial infarctions would also find OCs have an insignificant risk, |
| these studies would reassure OC users and would-be OC users concerned about cardiovascular effects. |
| (PubHealth.info Document ID: CONT3T 1530-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Is oral contraceptive use still associated with an increased |
| risk of fatal myocardial infarction? Report of a case-control study.", is(are) Thorogood M; Mann J; Murphy M; |
| Vessey M. The source of this article is "OBSTETRICAL AND GYNECOLOGICAL SURVEY. 1992 Jul;47(7):512-4.". |
| This article was published in 1992 in English language(s). (PubHealth.info® Document ID: CONT3T 1530-06. All |
| rights reserved with PubHealth.info) PIN: 11530 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |